Overview
- Two more children from Chhindwara died during treatment in Nagpur, bringing the official toll in the MP-linked cases to 24, with two additional children still receiving care.
- The World Health Organization issued an alert identifying three substandard cough syrups in India: Coldrif, Respifresh TR and ReLife.
- Laboratory testing in Madhya Pradesh found 48.6% diethylene glycol in one Coldrif sample, vastly exceeding the 0.1% impurity limit.
- Multiple states have banned Coldrif and Tamil Nadu revoked Sresan Pharma’s manufacturing licence and closed its facility.
- Investigators have made arrests, including a Chhindwara-based doctor and Sresan Pharma owner G Ranganathan, as criminal probes continue.